Back to Journals » Drug Design, Development and Therapy » Volume 16

Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights

Total article views   HTML views PDF downloads Totals
5,815 Dovepress* 5,674+ 359 6,033
PubMed Central* 141 83 224
Totals 5,815 442 6,257
*Since 16 May 2022

View citations on PubMed Central and Google Scholar